国产成人mv免费视频_无码精品毛片波多野吉衣_在线毛片äV网站免费观看_成人亚洲av电影_亚洲爆乳成av人在线网站_中国熟妇乱子hdsex粗_国产无遮挡污在线观看免费Aⅴ_日韩经典精品无码一区18_欧美巨大另类极品ⅴideosbest_午夜成人免费看在线观看

Pipeline

Product and Pipeline
Indication
Discovery
(Pre-clinical-Phase II)
Development
(Phase III)
Commercialization
Dorzagliatin
T2D - Drug Na?ve
T2D - Metformin Tolerated
RWE study for Diabetes Remission
Diabetes Prevention
Neurodegeneration
Dorzagliatin and Metformin FDC
T2D
Dorzagliatin + Empagliflozin
DKD
Dorzagliatin + Sitagliptin
T2D
Dorzagliatin add on to GLP1RA
T2D and Obesity
Dorzagliatin add on to Insulin
T1D
2nd Generation GKA
Metabolic Disease
mGLUR5 NAM
PD-LID
Drug Addiction
GK NAM
Metabolic Disease
Dorzagliatin
Discovery
(Pre-clinical-Phase II)
Development
(Phase III)
Commercialization
T2D - Drug Na?ve
T2D - Metformin Tolerated
RWE study for Diabetes Remission
Diabetes Prevention
Neurodegeneration
Dorzagliatin and Metformin FDC
Discovery
(Pre-clinical-Phase II)
Development
(Phase III)
Commercialization
T2D
Dorzagliatin + Empagliflozin
Discovery
(Pre-clinical-Phase II)
Development
(Phase III)
Commercialization
DKD
Dorzagliatin + Sitagliptin
Discovery
(Pre-clinical-Phase II)
Development
(Phase III)
Commercialization
T2D
Dorzagliatin add on to GLP1RA
Discovery
(Pre-clinical-Phase II)
Development
(Phase III)
Commercialization
T2D and Obesity
Dorzagliatin add on to Insulin
Discovery
(Pre-clinical-Phase II)
Development
(Phase III)
Commercialization
T1D
2nd Generation GKA
Discovery
(Pre-clinical-Phase II)
Development
(Phase III)
Commercialization
Metabolic Disease
mGLUR5 NAM
Discovery
(Pre-clinical-Phase II)
Development
(Phase III)
Commercialization
PD-LID
Drug Addiction
GK NAM
Discovery
(Pre-clinical-Phase II)
Development
(Phase III)
Commercialization
Metabolic Disease
Focus Us
Copyright ? 2024  Hua Medicine (Shanghai) Co., Ltd.    互聯(lián)網(wǎng)藥品信息服務(wù)資格證書(shū)編號(hào): (滬)-非經(jīng)營(yíng)-2022-0079
滬ICP備14036654號(hào)-1  beiantubiao.png 滬公網(wǎng)安備 31011502013809號(hào)  Privacy Statement  Terms of Use
Search
How we use cookies
Hua Medicine uses cookies to enable and improve the use of the website. By continuing to use the site, you consent to the use of these cookies. To learn more about cookies, please read our privacy statement.
Accept
x